Liang Peng

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Locally Advanced

Neoadjuvant Chemotherapy

Top Venues

Cancer medicine

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Guang-Li Zhu, Kai-Bin Yang, Si-Qi Tang, Liang Peng
Progression-free survival assessed per immune-related or conventional response criteria, which is the better surrogate endpoint for overall survival in trials of immune-checkpoint inhibitors in lung cancer: A systematic review and meta-analysis. Cancer medicine 10 (23) (2021)
Liang Peng, Jia-Luo Chen, Guang-Li Zhu, Cheng-Long Huang, Jun-Yan Li, Jun Ma, Wei-Ping Wen, Ling-Long Tang
Treatment effects of cumulative cisplatin dose during radiotherapy following induction chemotherapy in nasopharyngeal carcinoma: propensity score analyses. Therapeutic advances in medical oncology 12 (2020)
Hui Chang, Liang Peng, Ya-Lan Tao, Chen Chen, Wei-Wei Xiao, Yong-Hong Hu, Yuan-Hong Gao
Necessity of concurrent chemotherapy in N2-3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity-modulated radiotherapy. Cancer medicine 8 (6) (2019)
Cheng-Long Huang, Hong-Wen Tan, Rui Guo, Yuan Zhang, Hao Peng, Liang Peng, Ai-Hua Lin, Yan-Ping Mao, Yuyao Sun, Jun Ma, Ling-Long Tang
Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study. Cancer medicine 8 (16) (2019)
Liang Peng, Yi Yang, Rui Guo, Yan-Ping Mao, Cheng Xu, Yu-Pei Chen, Yuyao Sun, Jun Ma, Ling-Long Tang
Relationship between pretreatment concentration of plasma Epstein-Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation. Cancer medicine 7 (12) (2018)